Sign in
4/A

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-074399

HEAD OF R&D, COO-NOVITIUM OPS sold 50,000 shares at an average $51.70 ($2,584,912)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Shanmugam Muthusamy · HEAD OF R&D, COO-NOVITIUM OPS

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-20 Sale : show line 1 in the form 10b5-1 −14,657 $51.93 $761,138 1,317,963 I
2023-06-21 Sale : show line 2 in the form 10b5-1 −11,843 $51.95 $615,244 1,306,120 I
2023-06-22 Sale : show line 3 in the form 10b5-1 −13,500 $51.38 $693,630 1,292,620 I
2023-06-23 Sale : show line 4 in the form 10b5-1 −10,000 $51.49 $514,900 1,282,620 I
Open-market sales · 50,000 sh · avg $51.70 · $2,584,912
Loading xslF345X04/tm2319615-2_4aseq1.xml…